Cargando…
Dermatomyositis Flare After a COVID-19 Infection Successfully Treated with Rituximab: A Case Report and Literature Review
INTRODUCTION: Since the beginning of the coronavirus disease 2019 (COVID-19) pandemic, there has been a sudden surge in the incidence of several immune-mediated diseases, including dermatomyositis. The reported cases of COVID-19-related dermatomyositis are heterogeneous in their clinical presentatio...
Autores principales: | Albakri, Ahmed Mohammed, Subki, Ahmed Hussein, Albeity, Abdurahman, Halabi, Hussein |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9637344/ https://www.ncbi.nlm.nih.gov/pubmed/36348728 http://dx.doi.org/10.2147/JIR.S369477 |
Ejemplares similares
-
Spontaneous Pneumomediastinum and Subcutaneous Emphysema in Dermatomyositis: A Case Series and Literature Review
por: Subki, Ahmed Hussein, et al.
Publicado: (2023) -
Severe Primary Raynaud's Disease Treated with Rituximab
por: Shabrawishi, Mohammed, et al.
Publicado: (2016) -
A Case of Rituximab Use as an Induction and Maintenance of Remission in ANCA-Associated Vasculitis
por: Awad, Neveen, et al.
Publicado: (2016) -
Dermatomyositis: An Acute Flare and Current Treatments
por: Okogbaa, John, et al.
Publicado: (2019) -
Rituximab-Associated Flare of Cryoglobulinemic Vasculitis
por: Sy-Go, Janina Paula T., et al.
Publicado: (2021)